Factors associated with the consumption of psychotropic drugs in a cohort of men and women aged 50 and over

Journal of Clinical Pharmacy and Therapeutics

Volumn 28, Issue 1, 2003, Pages 61-68

  Empereur, F ^a   Baumann, Michéle ^a   Alla, F ^a   Briancon S ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Drug consumption; France; Health status; Medical factors; Psychotropic drugs; Sociodemographic factors

Indexed keywords

ANTIDEPRESSANT AGENT; HYPNOTIC AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SEDATIVE AGENT;

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; DEPRESSION; FEMALE; HEALTH STATUS; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; MEDICAL INFORMATION; MENTAL DISEASE; OCCUPATION; PERCEPTION; QUESTIONNAIRE; WIDOW;

AGE FACTORS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; COHORT STUDIES; DEMOGRAPHY; DEPRESSION; DRUG UTILIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PSYCHOTROPIC DRUGS; QUESTIONNAIRES; REGRESSION ANALYSIS; WIDOWHOOD;

EID: 0037294262     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2003.00464.x     Document Type: Article

References (36)

1. Mormiche P. (1994) Deux décennies d'évolution des consommations médicales. Enquête décennale 1991-1992. Paris: CREDES.
2. Hadsall R, Freeman R, Norwood J. (1982) Factors related to the prescribing of selected psychotropic drugs by primary care physicians. Social Science & Medicine, 16, 1747-1756.
3. Balter MB, Manheimer DI, Mellinger GD, Uhlenhuth EH. (1984) A cross-national comparison of anti-anxiety/sedative drug use. Current Medical Research and Opinion, 4, 5-20.
4. Ohayon MM, Caulet M, Priest RG, Guilleminault C. (1998) Psychotropic medication consumption in the UK general population. Journal of Clinical Epidemiology, 51, 273-283.
5. Legrain M, Lecomte T. (1988) The consumption of psychotropics in France and some European countries. Annals Pharmaceutiques Francaises, 56, 67-75.
6. Ankri J. (1999) (sous la direction). Dossier médicament et santé publique. ADSP, 27, 20-64.
7. Pelissolo A, Boyer P, Lepine JP, Bisserbe JC. (1996) Epidémiologie de la consommation des anxiolytiques et des hypnotiques en France et dans le monde. Encéphale, 22, 187-196.
8. Dealberto MJ, Seeman T, McAvay GJ, Berkman L. (1997) Factors related to current and subsequent psychotropic drug use in an ederly cohort. Journal of Clinical Epidemiology, 50, 357-364.
9. Le Moigne P. (2000) Anxiolytiques, hypnotiques. Les données sociales du recours. Swiss Journal of Sociology, 26, 71-109.
10. Blennow G, Romelsjö A, Leifman H, Leifman A, Karlsson G. (1994) Sedatives and hypnotics in Stockholm: social factors and kinds of use. American Journal of Public Health, 84, 242-246.
11. Swartz M, Landerman R, George LK, Melville ML, Blazer D, Smith K. (1991) Benzodiazepine anti-anxiety agents: prevalence and correlates of use in a southern community. American Journal of Public Health, 81, 592-596.
12. Chambaretaud S. (2000) La consommation des medicaments dans les principaux pays industrialisés. Direction de la Recherche des Etudes de l'Evaluation et des Statistiques, 47, 1-8.
13. Simoni-Wastila L. (1998) Gender and psychotropic drug use. Medical Care, 36, 88-94.
14. Graham K, Vidal-Zeballos D. (1998) Analyse of use of tranquilizers and sleeping pills across five surveys of the same population (1985-1991): the relationship with gender, age and use of user substances. Social Science and Medicine, 46, 381-385.
15. Baumann M, Pommier J, Deschamps JP. (1996) Prescription médicale et consommation de psychotropes: quelques interrogations sur les differences entre hommes et femmes. Cahiers de Sociologie et Démographie Médicale, 1, 63-78.
16. Ogur B. (1986) Long day's journey into night: women and prescription drug abuse. Women and Health, 11, 99-115.
17. Mant A, Duncan-Jones P, Saltman D et al. (1998) Development of long term use of psychotropic drugs by general pratice patients. British Medical Journal, 296, 251-254.
18. Hercberg S, Preziosi P, Briançon S et al. (1998) A primary prevention trial using nutritional doses of antioxydant vitamins and minerals in cardiovascular diseases and cancers in general population: 'the SU.VI.MAX. study'. Design, methods and participant characteristics. Controlled Clinical Trials, 19, 336-351.
19. Hercberg S, Preziosi P, Briançon S et al. (1998) Background and rationale behind the SUVIMAX Study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancers. International Journal of Vitamins and Nutrition Research, 68, 3-20.
20. Vidal (1997) Dictionnaire VIDAL. Paris: VIDAL (ed.).
21. Cafferata GL, Meyers SM. (1990) Pathways to Psychotropic drugs. Understanding the basis of gender differences. Medical Care, 28, 285-300.
22. Cooperstock R, Parnell P. (1982) Research on psychotropic drug use a review of findings and methods. Social Science & Medicine, 16, 1179-1196.
23. Cafferata GL, Kasper J, Bernstein A. (1983) Family roles, structure, and stressors in relation to sex differences in obtaining psychotropic drugs. Journal of Health and Social Behavior, 24, 132-143.
24. Saurel MJ, Blondel B. (1994) La santé des femmes. Paris: Flammarion, (ed.).
25. Cornfield J. (1967) Discriminant function. Review of the International Statistical Institute, 35, 142-153.
26. Dixon W, Brown M, Engelman L, Jenrich R. (1990) BMDP Statistical Software. Berkeley: University of California Press.
27. Guignon N. (1994) Les consommations d'alcool, de tabac et de psychotropes en France en 1991-1992. Solidarite Sante, 1, 1-16.
28. Ashton H. (1991) Psychotropic-drug prescribing for women. British Journal of Psychiatry, 158, 30-35.
29. Hohmann AA. (1989) Gender bias in psychotropic drug prescribing in primary care. Medical Care, 27, 478-490.
30. Trinkoff AM, Anthony JC. (1990) Gender differences in initiation of psychotherapeutic medicine use. Acta Psychiatrica Scandinavia, 81, 32-38.
31. Mellinger GD, Balter MB, Uhlenhuth E. (1984) Prevalence and correlates of the long-term regular use of anxiolytics. Journal of the American Medical Association, 251, 375-379.
32. Hemminki E. (1975) Review of literature on the factors affecting drug prescribing. Social Science & Medicine, 9, 111-115.
33. Ried LD, Christensen dB, Stergachis A. (1990) Medical and psychosocial factors predictive of psychotropic drug use in elderly patients. American Journal of Public Health, 80, 1349-1353.
34. Ferley JP, Balducci F, Charrel M, Drucker J. (1988) Frequence des troubles du sommeil et recours aux somnifères chez les habitants d'une ville moyenne. Identification de facteurs associés. Revue Française de Santé Publique, 41, 24-29.
35. Cans C, Rotily M. (1991) La consommation de psychotropes en population générale dans le département de l'Isère. Revue d'epidemiologie et de sante Publique, 39, 515-522.
36. Balter MB, Levine J, Manheimer D. (1974) Cross-national study of the extent of anti-anxiety/sedative drug use. New England Journal of Medicine, 290, 769-774.